4//SEC Filing
ACURA PHARMACEUTICALS, INC 4
Accession 0001209191-14-017134
$ACURCIK 0000786947operating
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 1:41 PM ET
Size
12.4 KB
Accession
0001209191-14-017134
Insider Transaction Report
Form 4
GALEN EMPLOYEE FUND III LP
10% Owner
Transactions
- Sale
Common Stock
2014-03-03$2.00/sh−2,500$5,000→ 11,128,618 total(indirect: See FN)
GALEN PARTNERS INTERNATIONAL III L P
10% Owner
Transactions
- Sale
Common Stock
2014-03-03$2.00/sh−2,500$5,000→ 11,128,618 total(indirect: See FN)
Galen Management, LLC
10% Owner
Transactions
- Sale
Common Stock
2014-03-03$2.00/sh−2,500$5,000→ 11,128,618 total(indirect: See FN)
GALEN PARTNERS III L P
10% Owner
Transactions
- Sale
Common Stock
2014-03-03$2.00/sh−2,500$5,000→ 11,128,618 total(indirect: See FN)
CLAUDIUS LLC
10% Owner
Transactions
- Sale
Common Stock
2014-03-03$2.00/sh−2,500$5,000→ 11,128,618 total(indirect: See FN)
Footnotes (2)
- [F1]The shares were sold as follows: 2,284 by Galen Partners III, L.P. ("Galen III"), 207 by Galen Partners International III, L.P. ("Galen International") and 9 by Galen Employee Fund III, L.P. ("Employee Fund").
- [F2]The shares are held as follows: 10,169,675 by Galen III, 917,052 by Galen International and 41,894 by Employee Fund. Claudius, L.L.C. serves as the sole General Partner of Galen III and Galen International and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Galen Management, L.L.C. serves as the sole General Partner of Employee Fund and has sole voting and investment control over the shares held by Employee Fund and may be deemed to beneficially own the shares held by Employee Fund. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000786947
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 1:41 PM ET
- Size
- 12.4 KB